Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012;13(11):5525-8.
doi: 10.7314/apjcp.2012.13.11.5525.

Standardized breast cancer mortality rate compared to the general female population of Iran

Affiliations
Free article
Comparative Study

Standardized breast cancer mortality rate compared to the general female population of Iran

S Haghighat et al. Asian Pac J Cancer Prev. 2012.
Free article

Abstract

Introduction: Breast cancer is the most common cancer in women. Improvements of early diagnosis modalities have led to longer survival rates. This study aimed to determine the 5, 10 and 15 year mortality rates of breast cancer patients compared to the normal female population.

Materials and methods: The follow up data of a cohort of 615 breast cancer patients referred to Iranian Breast Cancer Research Center (BCRC) from 1986 to 1996 was considered as reference breast cancer dataset. The dataset was divided into 5 year age groups and the 5, 10 and 15 year probability of death for each group was estimated. The annual mortality rate of Iranian women was obtained from the Death Registry system. Standardized mortality ratios (SMRs) of breast cancer patients were calculated using the ratio of the mortality rate in breast cancer patients over the general female population.

Results: The mean age of breast cancer patients at diagnosis time was 45.9 (±10.5) years ranging from 24-74. A total of 73, 32 and 2 deaths were recorded at 5, 10 and 15 years, respectively, after diagnosis. The SMRs for breast cancer patients at 5, 10 and 15 year intervals after diagnosis were 6.74 (95% CI, 5.5- 8.2), 6.55 (95%CI, 5-8.1) and 1.26 (95%CI, 0.65-2.9), respectively.

Conclusion: Results showed that the observed mortality rate of breast cancer patients after 15 years from diagnosis was very similar to expected rates in general female population. This finding would be useful for clinicians and health policy makers to adopt a beneficial strategy to improve breast cancer survival. Further follow-up time with larger sample size and a pooled analysis of survival rates of different centres may shed more light on mortality patterns of breast cancer.

PubMed Disclaimer

Similar articles

  • Increased trend of breast cancer mortality in Iran.
    Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, Pourhoseingholi MA. Taghavi A, et al. Asian Pac J Cancer Prev. 2012;13(1):367-70. doi: 10.7314/apjcp.2012.13.1.367. Asian Pac J Cancer Prev. 2012. PMID: 22502702
  • Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group. Christiansen P, et al. J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31. J Natl Cancer Inst. 2011. PMID: 21881042
  • Burden of Breast Cancer in Iranian Women is Increasing.
    Sharifian A, Pourhoseingholi MA, Emadedin M, Rostami Nejad M, Ashtari S, Hajizadeh N, Firouzei SA, Hosseini SJ. Sharifian A, et al. Asian Pac J Cancer Prev. 2015;16(12):5049-52. doi: 10.7314/apjcp.2015.16.12.5049. Asian Pac J Cancer Prev. 2015. PMID: 26163639
  • Relative Survival of Breast Cancer Patients in Iran.
    Mosavi-Jarrahi A, Abadi A, Mehrabi Y, Mahmoodi M, Eshraghian MR, Mohammad K, Mardani-Fard HA, Kasaeian A. Mosavi-Jarrahi A, et al. Asian Pac J Cancer Prev. 2015;16(14):5853-8. doi: 10.7314/apjcp.2015.16.14.5853. Asian Pac J Cancer Prev. 2015. PMID: 26320462
  • Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    AIRTUM Working Group; Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L. AIRTUM Working Group, et al. Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748

Cited by

Publication types